Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Emily McDonald and Sarah Lofgren.
Emily McDonald
Connection Strength
0.565
Sarah Lofgren
  1. Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa500.
    View in: PubMed
    Score: 0.227
  2. Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial. Clin Infect Dis. 2021 06 01; 72(11):e835-e843.
    View in: PubMed
    Score: 0.059
  3. Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic. Open Forum Infect Dis. 2021 Feb; 8(2):ofaa602.
    View in: PubMed
    Score: 0.058
  4. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. Ann Intern Med. 2020 10 20; 173(8):623-631.
    View in: PubMed
    Score: 0.056
  5. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 08 06; 383(6):517-525.
    View in: PubMed
    Score: 0.055
  6. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial. Can J Anaesth. 2020 09; 67(9):1201-1211.
    View in: PubMed
    Score: 0.055
  7. Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19). Open Forum Infect Dis. 2020 Apr; 7(4):ofaa130.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.